Blogs

Stay informed with expert insights, trends, and best practices in life sciences compliance.

How the U.S. Department of Justice Recovered $4.7 Billion in 2016?

The United States Department of Justice made an annual announcement on December 14, 2016 in which the amount of money that was recovered in 2016 in Civil False Claims Act settlements and judgments during the fiscal year 2016 were reported. As per the announcement, the DoJ recovered over $4.7 billion from businesses and individuals who […]

How EU Member Counties Are Approaching the Issue of Consent Under Data Protection Laws

Although physician consent requirements are widespread across Europe, the fact is that different EU member countries have different rules surrounding the issue. Out of all, around 14 countries have a law or code in place, five countries (including France, Portugal, Romania, Netherlands, and Denmark) do not require consent, five countries (including Greece, Austria, Luxembourg, Hungary […]

Execs & Physicians at Doc-Owned Hospital Chain Indicted in Alleged Kickback Scheme

Law enforcement authorities have indicted executives and physicians affiliated with the physician-owned Forest Park Medical Center for allegedly paying or accepting bribes and kickbacks in exchange for referring patients to the hospital. According to an announcement released by the Department of Justice, top-level executives and doctors affiliated with the hospital had established shell companies and […]

Highlights of the 3rd Annual Global Compliance Congress for Life Sciences

The 3rd Annual Global Compliance Congress for Life Sciences was held by the CBI at the Hilton London Olympia on the 16th & 17th of November, 2016. The conference provided an excellent platform for representatives of life sciences companies to network, share ideas and learn from one another. The ambiance at the conference was high-energy […]

Challenges in Seeking HCP/O Consent Under the Data Protection Laws of The EU

For most pharma companies in the EU, seeking the consent of the HCP’s/HCO’s that they indulge in transactions is the most appropriate means of ensuring compliance with data protection laws when disclosing their spending under the EFPIA disclosure code. Indeed, the Code comes with guidance notes that place special emphasis on pharmaceutical companies seeking consent […]

Sunshine Act Reporting Challenges & How to Tackle Them

As the reporting date under the US Sunshine Act approaches, compliance teams are working harder than ever to collect spend records and have them audited and ready to submit to CMS. If anything, the frenzy of resolving system issues, vendor management, and personnel challenges makes it extremely hard for most compliance teams to reach the […]